Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation

To provide long-term outcome data and predictors for response and survival, we retrospectively analyzed all 151 patients with relapse of myeloid neoplasms after allogeneic hematopoietic stem cell transplantation (allo-HSCT) who were uniformly treated with first-line azacitidine (Aza) salvage therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rautenberg, Christina, Bergmann, Anika, Germing, Ulrich, Fischermanns, Caroline, Pechtel, Sabrina, Kaivers, Jennifer, Jäger, Paul, Schuler, Esther, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464210/
https://www.ncbi.nlm.nih.gov/pubmed/32806572
http://dx.doi.org/10.3390/cancers12082255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464210/
https://www.ncbi.nlm.nih.gov/pubmed/32806572
http://dx.doi.org/10.3390/cancers12082255

Ejemplares similares